instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hand fracture'. | Fracture Risk Following an Atypical Femoral Fracture.
Atypical femoral fractures (AFFs) occurring during the course of osteoporosis treatment usually lead to discontinuation of anti-resorptive (AR) drugs. However, the risk of fracture after an AFF is unknown. We conducted a follow-up study of patients with AFF matched ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34668223 | 20,521,477 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hip fracture'. | Fracture Risk Following an Atypical Femoral Fracture.
Atypical femoral fractures (AFFs) occurring during the course of osteoporosis treatment usually lead to discontinuation of anti-resorptive (AR) drugs. However, the risk of fracture after an AFF is unknown. We conducted a follow-up study of patients with AFF matched ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34668223 | 20,521,477 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Humerus fracture'. | Fracture Risk Following an Atypical Femoral Fracture.
Atypical femoral fractures (AFFs) occurring during the course of osteoporosis treatment usually lead to discontinuation of anti-resorptive (AR) drugs. However, the risk of fracture after an AFF is unknown. We conducted a follow-up study of patients with AFF matched ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34668223 | 20,521,477 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Impaired healing'. | Fracture Risk Following an Atypical Femoral Fracture.
Atypical femoral fractures (AFFs) occurring during the course of osteoporosis treatment usually lead to discontinuation of anti-resorptive (AR) drugs. However, the risk of fracture after an AFF is unknown. We conducted a follow-up study of patients with AFF matched ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34668223 | 20,521,477 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteoporotic fracture'. | Fracture Risk Following an Atypical Femoral Fracture.
Atypical femoral fractures (AFFs) occurring during the course of osteoporosis treatment usually lead to discontinuation of anti-resorptive (AR) drugs. However, the risk of fracture after an AFF is unknown. We conducted a follow-up study of patients with AFF matched ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34668223 | 20,521,477 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Patella fracture'. | Fracture Risk Following an Atypical Femoral Fracture.
Atypical femoral fractures (AFFs) occurring during the course of osteoporosis treatment usually lead to discontinuation of anti-resorptive (AR) drugs. However, the risk of fracture after an AFF is unknown. We conducted a follow-up study of patients with AFF matched ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34668223 | 20,521,477 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pelvic fracture'. | Fracture Risk Following an Atypical Femoral Fracture.
Atypical femoral fractures (AFFs) occurring during the course of osteoporosis treatment usually lead to discontinuation of anti-resorptive (AR) drugs. However, the risk of fracture after an AFF is unknown. We conducted a follow-up study of patients with AFF matched ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34668223 | 20,521,477 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rib fracture'. | Fracture Risk Following an Atypical Femoral Fracture.
Atypical femoral fractures (AFFs) occurring during the course of osteoporosis treatment usually lead to discontinuation of anti-resorptive (AR) drugs. However, the risk of fracture after an AFF is unknown. We conducted a follow-up study of patients with AFF matched ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34668223 | 20,521,477 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Scapula fracture'. | Fracture Risk Following an Atypical Femoral Fracture.
Atypical femoral fractures (AFFs) occurring during the course of osteoporosis treatment usually lead to discontinuation of anti-resorptive (AR) drugs. However, the risk of fracture after an AFF is unknown. We conducted a follow-up study of patients with AFF matched ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34668223 | 20,521,477 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Spinal fracture'. | Fracture Risk Following an Atypical Femoral Fracture.
Atypical femoral fractures (AFFs) occurring during the course of osteoporosis treatment usually lead to discontinuation of anti-resorptive (AR) drugs. However, the risk of fracture after an AFF is unknown. We conducted a follow-up study of patients with AFF matched ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34668223 | 20,521,477 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Upper limb fracture'. | Fracture Risk Following an Atypical Femoral Fracture.
Atypical femoral fractures (AFFs) occurring during the course of osteoporosis treatment usually lead to discontinuation of anti-resorptive (AR) drugs. However, the risk of fracture after an AFF is unknown. We conducted a follow-up study of patients with AFF matched ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34668223 | 20,521,477 | 2021-10-20 |
What was the outcome of reaction 'Atypical femur fracture'? | Fracture Risk Following an Atypical Femoral Fracture.
Atypical femoral fractures (AFFs) occurring during the course of osteoporosis treatment usually lead to discontinuation of anti-resorptive (AR) drugs. However, the risk of fracture after an AFF is unknown. We conducted a follow-up study of patients with AFF matched ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34668223 | 20,521,477 | 2021-10-20 |
What was the outcome of reaction 'Osteoporotic fracture'? | Fracture Risk Following an Atypical Femoral Fracture.
Atypical femoral fractures (AFFs) occurring during the course of osteoporosis treatment usually lead to discontinuation of anti-resorptive (AR) drugs. However, the risk of fracture after an AFF is unknown. We conducted a follow-up study of patients with AFF matched ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34668223 | 20,521,477 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | METHOTREXATE | DrugsGivenReaction | CC BY | 34669022 | 20,063,984 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Central nervous system lymphoma'. | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | METHOTREXATE | DrugsGivenReaction | CC BY | 34669022 | 20,898,407 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Delirium'. | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | METHOTREXATE | DrugsGivenReaction | CC BY | 34669022 | 20,063,984 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal infection'. | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | METHOTREXATE | DrugsGivenReaction | CC BY | 34669022 | 20,063,984 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal inflammation'. | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | METHOTREXATE | DrugsGivenReaction | CC BY | 34669022 | 20,898,407 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukopenia'. | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | METHOTREXATE | DrugsGivenReaction | CC BY | 34669022 | 20,063,984 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | METHOTREXATE | DrugsGivenReaction | CC BY | 34669022 | 20,898,407 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple organ dysfunction syndrome'. | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | METHOTREXATE | DrugsGivenReaction | CC BY | 34669022 | 20,895,568 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neurotoxicity'. | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | METHOTREXATE | DrugsGivenReaction | CC BY | 34669022 | 20,898,407 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | METHOTREXATE | DrugsGivenReaction | CC BY | 34669022 | 20,898,409 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | METHOTREXATE | DrugsGivenReaction | CC BY | 34669022 | 20,895,568 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | METHOTREXATE | DrugsGivenReaction | CC BY | 34669022 | 20,063,984 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | METHOTREXATE | DrugsGivenReaction | CC BY | 34669022 | 20,063,984 | 2021-10-20 |
What was the administration route of drug 'METHOTREXATE'? | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34669022 | 20,063,984 | 2021-10-20 |
What was the outcome of reaction 'Central nervous system lymphoma'? | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | Fatal | ReactionOutcome | CC BY | 34669022 | 20,898,407 | 2021-10-20 |
What was the outcome of reaction 'Delirium'? | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | Fatal | ReactionOutcome | CC BY | 34669022 | 20,898,407 | 2021-10-20 |
What was the outcome of reaction 'Gastrointestinal inflammation'? | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | Fatal | ReactionOutcome | CC BY | 34669022 | 20,898,407 | 2021-10-20 |
What was the outcome of reaction 'Leukopenia'? | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | Fatal | ReactionOutcome | CC BY | 34669022 | 20,898,407 | 2021-10-20 |
What was the outcome of reaction 'Malignant neoplasm progression'? | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | Fatal | ReactionOutcome | CC BY | 34669022 | 20,898,407 | 2021-10-20 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | Fatal | ReactionOutcome | CC BY | 34669022 | 20,895,568 | 2021-10-20 |
What was the outcome of reaction 'Neurotoxicity'? | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | Fatal | ReactionOutcome | CC BY | 34669022 | 20,898,407 | 2021-10-20 |
What was the outcome of reaction 'Pneumonia'? | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | Fatal | ReactionOutcome | CC BY | 34669022 | 20,895,568 | 2021-10-20 |
What was the outcome of reaction 'Thrombocytopenia'? | Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
OBJECTIVE
High-dose methotrexate (HDMTX)-associated acute kidney injury with delayed MTX clearance has been linked to an excess in MTX-induced toxicities. Glucarpidase is a recombinant enzyme that rapidly hydr... | Fatal | ReactionOutcome | CC BY | 34669022 | 20,898,407 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Bacteremia after Bacillus clausii administration for the treatment of acute diarrhea: A case report.
Bacillus clausii is a gram-positive rod used as a probiotic to treat diarrhea and the side effects of antibiotics such as pseudomembranous colitis. We report a case of B. clausii bacteremia in a non-immunocompromised pa... | AMPICILLIN SODIUM\SULBACTAM SODIUM, BACILLUS SUBTILIS, CEFEPIME HYDROCHLORIDE, CEPHALOTHIN, PROBIOTICS NOS, VANCOMYCIN | DrugsGivenReaction | CC BY | 34669274 | 20,467,344 | 2021-10-15 |
What was the administration route of drug 'VANCOMYCIN'? | Bacteremia after Bacillus clausii administration for the treatment of acute diarrhea: A case report.
Bacillus clausii is a gram-positive rod used as a probiotic to treat diarrhea and the side effects of antibiotics such as pseudomembranous colitis. We report a case of B. clausii bacteremia in a non-immunocompromised pa... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34669274 | 20,467,344 | 2021-10-15 |
What was the dosage of drug 'BACILLUS SUBTILIS'? | Bacteremia after Bacillus clausii administration for the treatment of acute diarrhea: A case report.
Bacillus clausii is a gram-positive rod used as a probiotic to treat diarrhea and the side effects of antibiotics such as pseudomembranous colitis. We report a case of B. clausii bacteremia in a non-immunocompromised pa... | (2 BILLION/5 ML B. CLAUSII SPORE SUSPENSION, STRAINS: | DrugDosageText | CC BY | 34669274 | 20,467,344 | 2021-10-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Small intestine carcinoma metastatic'. | Nine-Year Follow-Up of a Huge Retroperitoneal Alveolar Soft-Part Sarcoma: A Case Report.
BACKGROUND Alveolar soft-part sarcoma is an uncommon mesenchymal tumor accounting for approximately 0.7% of soft tissue sarcomas in adults. It mainly affects young adults, with a peak incidence between 15 and 35 years old. Availabl... | PAZOPANIB | DrugsGivenReaction | CC BY-NC-ND | 34669689 | 20,142,356 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Nine-Year Follow-Up of a Huge Retroperitoneal Alveolar Soft-Part Sarcoma: A Case Report.
BACKGROUND Alveolar soft-part sarcoma is an uncommon mesenchymal tumor accounting for approximately 0.7% of soft tissue sarcomas in adults. It mainly affects young adults, with a peak incidence between 15 and 35 years old. Availabl... | PAZOPANIB, SUNITINIB | DrugsGivenReaction | CC BY-NC-ND | 34669689 | 20,105,020 | 2021-10-20 |
What is the weight of the patient? | Nine-Year Follow-Up of a Huge Retroperitoneal Alveolar Soft-Part Sarcoma: A Case Report.
BACKGROUND Alveolar soft-part sarcoma is an uncommon mesenchymal tumor accounting for approximately 0.7% of soft tissue sarcomas in adults. It mainly affects young adults, with a peak incidence between 15 and 35 years old. Availabl... | 54 kg. | Weight | CC BY-NC-ND | 34669689 | 20,142,356 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Influence of CYP2D6 metabolizer status on ondansetron efficacy in pediatric patients undergoing hematopoietic stem cell transplantation: A case series.
Chemotherapy-induced nausea and vomiting (CINV) is commonly experienced by patients receiving antineoplastic agents prior to hemopoietic stem cell transplant (HSCT). On... | ALEMTUZUMAB, AMIFOSTINE, DIPHENHYDRAMINE, GRANISETRON, LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN, MELPHALAN, ONDANSETRON | DrugsGivenReaction | CC BY-NC | 34670017 | 20,077,316 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Influence of CYP2D6 metabolizer status on ondansetron efficacy in pediatric patients undergoing hematopoietic stem cell transplantation: A case series.
Chemotherapy-induced nausea and vomiting (CINV) is commonly experienced by patients receiving antineoplastic agents prior to hemopoietic stem cell transplant (HSCT). On... | CYCLOPHOSPHAMIDE, DIPHENHYDRAMINE HYDROCHLORIDE, ONDANSETRON, PROMETHAZINE HYDROCHLORIDE, SCOPOLAMINE, THIOTEPA | DrugsGivenReaction | CC BY-NC | 34670017 | 20,895,782 | 2021-10-20 |
What was the administration route of drug 'ONDANSETRON'? | Influence of CYP2D6 metabolizer status on ondansetron efficacy in pediatric patients undergoing hematopoietic stem cell transplantation: A case series.
Chemotherapy-induced nausea and vomiting (CINV) is commonly experienced by patients receiving antineoplastic agents prior to hemopoietic stem cell transplant (HSCT). On... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34670017 | 20,077,316 | 2021-10-20 |
What was the dosage of drug 'ONDANSETRON'? | Influence of CYP2D6 metabolizer status on ondansetron efficacy in pediatric patients undergoing hematopoietic stem cell transplantation: A case series.
Chemotherapy-induced nausea and vomiting (CINV) is commonly experienced by patients receiving antineoplastic agents prior to hemopoietic stem cell transplant (HSCT). On... | 0.15 MG/KG EVERY 8 HOURS WITH A MAXIMUM DOSE OF 8 MG PER DOSE | DrugDosageText | CC BY-NC | 34670017 | 20,077,316 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adrenal insufficiency'. | Low dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma.
Mitotane is an adrenolytic drug that exhibits a therapeutic effect within a narrow target range (14-20 μg/dL). Various complications develop if the upper limit is exceeded. We present the case of... | HYDROCORTISONE, MITOTANE | DrugsGivenReaction | CC BY-NC | 34670067 | 20,034,630 | 2021-10-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Encephalopathy'. | Low dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma.
Mitotane is an adrenolytic drug that exhibits a therapeutic effect within a narrow target range (14-20 μg/dL). Various complications develop if the upper limit is exceeded. We present the case of... | HYDROCORTISONE, MITOTANE | DrugsGivenReaction | CC BY-NC | 34670067 | 20,034,630 | 2021-10-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epigastric discomfort'. | Low dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma.
Mitotane is an adrenolytic drug that exhibits a therapeutic effect within a narrow target range (14-20 μg/dL). Various complications develop if the upper limit is exceeded. We present the case of... | HYDROCORTISONE, MITOTANE | DrugsGivenReaction | CC BY-NC | 34670067 | 20,034,630 | 2021-10-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypercholesterolaemia'. | Low dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma.
Mitotane is an adrenolytic drug that exhibits a therapeutic effect within a narrow target range (14-20 μg/dL). Various complications develop if the upper limit is exceeded. We present the case of... | HYDROCORTISONE, MITOTANE | DrugsGivenReaction | CC BY-NC | 34670067 | 20,034,630 | 2021-10-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypothyroidism'. | Low dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma.
Mitotane is an adrenolytic drug that exhibits a therapeutic effect within a narrow target range (14-20 μg/dL). Various complications develop if the upper limit is exceeded. We present the case of... | HYDROCORTISONE, MITOTANE | DrugsGivenReaction | CC BY-NC | 34670067 | 20,034,630 | 2021-10-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Low dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma.
Mitotane is an adrenolytic drug that exhibits a therapeutic effect within a narrow target range (14-20 μg/dL). Various complications develop if the upper limit is exceeded. We present the case of... | HYDROCORTISONE, MITOTANE | DrugsGivenReaction | CC BY-NC | 34670067 | 20,034,630 | 2021-10-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Precocious puberty'. | Low dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma.
Mitotane is an adrenolytic drug that exhibits a therapeutic effect within a narrow target range (14-20 μg/dL). Various complications develop if the upper limit is exceeded. We present the case of... | HYDROCORTISONE, MITOTANE | DrugsGivenReaction | CC BY-NC | 34670067 | 20,034,630 | 2021-10-18 |
What is the weight of the patient? | Low dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma.
Mitotane is an adrenolytic drug that exhibits a therapeutic effect within a narrow target range (14-20 μg/dL). Various complications develop if the upper limit is exceeded. We present the case of... | 21.3 kg. | Weight | CC BY-NC | 34670067 | 20,034,630 | 2021-10-18 |
What was the administration route of drug 'MITOTANE'? | Low dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma.
Mitotane is an adrenolytic drug that exhibits a therapeutic effect within a narrow target range (14-20 μg/dL). Various complications develop if the upper limit is exceeded. We present the case of... | Oral | DrugAdministrationRoute | CC BY-NC | 34670067 | 20,034,630 | 2021-10-18 |
What was the dosage of drug 'MITOTANE'? | Low dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma.
Mitotane is an adrenolytic drug that exhibits a therapeutic effect within a narrow target range (14-20 μg/dL). Various complications develop if the upper limit is exceeded. We present the case of... | 1.25 G/M2/DAY, THEN 1.85 G/M2/DAY, 2.5 G/M2/DAY, 3 G/M2/DAY, 2.5 G/M2/DAY | DrugDosageText | CC BY-NC | 34670067 | 20,034,630 | 2021-10-18 |
What was the outcome of reaction 'Encephalopathy'? | Low dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma.
Mitotane is an adrenolytic drug that exhibits a therapeutic effect within a narrow target range (14-20 μg/dL). Various complications develop if the upper limit is exceeded. We present the case of... | Recovering | ReactionOutcome | CC BY-NC | 34670067 | 20,034,630 | 2021-10-18 |
What was the outcome of reaction 'Hypothyroidism'? | Low dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma.
Mitotane is an adrenolytic drug that exhibits a therapeutic effect within a narrow target range (14-20 μg/dL). Various complications develop if the upper limit is exceeded. We present the case of... | Not recovered | ReactionOutcome | CC BY-NC | 34670067 | 20,034,630 | 2021-10-18 |
What was the outcome of reaction 'Off label use'? | Low dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma.
Mitotane is an adrenolytic drug that exhibits a therapeutic effect within a narrow target range (14-20 μg/dL). Various complications develop if the upper limit is exceeded. We present the case of... | Recovered | ReactionOutcome | CC BY-NC | 34670067 | 20,034,630 | 2021-10-18 |
What was the outcome of reaction 'Precocious puberty'? | Low dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma.
Mitotane is an adrenolytic drug that exhibits a therapeutic effect within a narrow target range (14-20 μg/dL). Various complications develop if the upper limit is exceeded. We present the case of... | Not recovered | ReactionOutcome | CC BY-NC | 34670067 | 20,034,630 | 2021-10-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'C-reactive protein increased'. | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | ALENDRONATE SODIUM, APIXABAN, BUDESONIDE\FORMOTEROL, CALCIUM CARBONATE\VITAMIN D, DIGOXIN, ENALAPRIL, FUROSEMIDE, IOVERSOL, METHIMAZOLE, METOPROLOL SUCCINATE, SIMVASTATIN, UNSPECIFIED INGREDIENT, VERAPAMIL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | ALENDRONATE SODIUM, APIXABAN, BUDESONIDE\FORMOTEROL, CALCIUM CARBONATE\VITAMIN D, DIGOXIN, ENALAPRIL, FUROSEMIDE, IOVERSOL, METHIMAZOLE, METOPROLOL SUCCINATE, SIMVASTATIN, UNSPECIFIED INGREDIENT, VERAPAMIL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertrophic cardiomyopathy'. | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | ALENDRONATE SODIUM, APIXABAN, BUDESONIDE\FORMOTEROL, CALCIUM CARBONATE\VITAMIN D, DIGOXIN, ENALAPRIL, FUROSEMIDE, IOVERSOL, METHIMAZOLE, METOPROLOL SUCCINATE, SIMVASTATIN, UNSPECIFIED INGREDIENT, VERAPAMIL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoxia'. | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | ALENDRONATE SODIUM, APIXABAN, BUDESONIDE\FORMOTEROL, CALCIUM CARBONATE\VITAMIN D, DIGOXIN, ENALAPRIL, FUROSEMIDE, IOVERSOL, METHIMAZOLE, METOPROLOL SUCCINATE, SIMVASTATIN, UNSPECIFIED INGREDIENT, VERAPAMIL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Loss of consciousness'. | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | ALENDRONATE SODIUM, APIXABAN, BUDESONIDE\FORMOTEROL, CALCIUM CARBONATE\VITAMIN D, DIGOXIN, ENALAPRIL, FUROSEMIDE, IOVERSOL, METHIMAZOLE, METOPROLOL SUCCINATE, SIMVASTATIN, UNSPECIFIED INGREDIENT, VERAPAMIL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocardial ischaemia'. | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | ALENDRONATE SODIUM, APIXABAN, BUDESONIDE\FORMOTEROL, CALCIUM CARBONATE\VITAMIN D, DIGOXIN, ENALAPRIL, FUROSEMIDE, IOVERSOL, METHIMAZOLE, METOPROLOL SUCCINATE, SIMVASTATIN, UNSPECIFIED INGREDIENT, VERAPAMIL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oedema peripheral'. | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | ALENDRONATE SODIUM, APIXABAN, BUDESONIDE\FORMOTEROL, CALCIUM CARBONATE\VITAMIN D, DIGOXIN, ENALAPRIL, FUROSEMIDE, IOVERSOL, METHIMAZOLE, METOPROLOL SUCCINATE, SIMVASTATIN, UNSPECIFIED INGREDIENT, VERAPAMIL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pleural effusion'. | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | ALENDRONATE SODIUM, APIXABAN, BUDESONIDE\FORMOTEROL, CALCIUM CARBONATE\VITAMIN D, DIGOXIN, ENALAPRIL, FUROSEMIDE, IOVERSOL, METHIMAZOLE, METOPROLOL SUCCINATE, SIMVASTATIN, UNSPECIFIED INGREDIENT, VERAPAMIL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | ALENDRONATE SODIUM, APIXABAN, BUDESONIDE\FORMOTEROL, CALCIUM CARBONATE\VITAMIN D, DIGOXIN, ENALAPRIL, FUROSEMIDE, IOVERSOL, METHIMAZOLE, METOPROLOL SUCCINATE, SIMVASTATIN, UNSPECIFIED INGREDIENT, VERAPAMIL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Subendocardial ischaemia'. | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | ALENDRONATE SODIUM, APIXABAN, BUDESONIDE\FORMOTEROL, CALCIUM CARBONATE\VITAMIN D, DIGOXIN, ENALAPRIL, FUROSEMIDE, IOVERSOL, METHIMAZOLE, METOPROLOL SUCCINATE, SIMVASTATIN, UNSPECIFIED INGREDIENT, VERAPAMIL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tachycardia'. | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | ALENDRONATE SODIUM, APIXABAN, BUDESONIDE\FORMOTEROL, CALCIUM CARBONATE\VITAMIN D, DIGOXIN, ENALAPRIL, FUROSEMIDE, IOVERSOL, METHIMAZOLE, METOPROLOL SUCCINATE, SIMVASTATIN, UNSPECIFIED INGREDIENT, VERAPAMIL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic response decreased'. | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | APIXABAN, BUDESONIDE\FORMOTEROL, CALCIUM CARBONATE\CHOLECALCIFEROL, DIGOXIN, ENALAPRIL, FUROSEMIDE, METHIMAZOLE, METOPROLOL, SIMVASTATIN, VERAPAMIL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34670545 | 20,592,717 | 2021-10-20 |
What was the administration route of drug 'IOVERSOL'? | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
What was the dosage of drug 'IOVERSOL'? | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | 741 MG/ML | DrugDosageText | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
What was the dosage of drug 'METOPROLOL SUCCINATE'? | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | DOSE WAS INCREASED | DrugDosageText | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
What was the dosage of drug 'METOPROLOL'? | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | (DOSE INCREASED) | DrugDosageText | CC BY | 34670545 | 20,567,846 | 2021-10-20 |
What was the outcome of reaction 'Cardiac failure'? | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | Not recovered | ReactionOutcome | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
What was the outcome of reaction 'Drug ineffective'? | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | Not recovered | ReactionOutcome | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
What was the outcome of reaction 'Hypertrophic cardiomyopathy'? | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | Not recovered | ReactionOutcome | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
What was the outcome of reaction 'Hypoxia'? | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | Not recovered | ReactionOutcome | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
What was the outcome of reaction 'Loss of consciousness'? | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | Not recovered | ReactionOutcome | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
What was the outcome of reaction 'Myocardial ischaemia'? | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | Fatal | ReactionOutcome | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
What was the outcome of reaction 'Pneumonia'? | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | Fatal | ReactionOutcome | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
What was the outcome of reaction 'Subendocardial ischaemia'? | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | Not recovered | ReactionOutcome | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
What was the outcome of reaction 'Tachycardia'? | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | Fatal | ReactionOutcome | CC BY | 34670545 | 20,906,385 | 2021-10-20 |
What was the outcome of reaction 'Therapeutic response decreased'? | Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.
BACKGROUND
exposure to iodinated contrast media (ICM) can cause hyperthyroidism, due to disruption of thyroid hormone regulation. Although rare, it can have severe consequences and can lead to fatal complications. Curren... | Fatal | ReactionOutcome | CC BY | 34670545 | 20,592,717 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Vertebral artery dissection in term pregnancy after cervical spine manipulation: a case report and review the literature.
BACKGROUND
Vertebral artery dissection is an uncommon, but potentially fatal, vascular event. This case aimed to describe the pathogenesis and clinical presentation of vertebral artery dissection in... | ASPIRIN, LEVOSULPIRIDE, PREDNISONE | DrugsGivenReaction | CC BY | 34670622 | 20,153,936 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Vertebral artery dissection in term pregnancy after cervical spine manipulation: a case report and review the literature.
BACKGROUND
Vertebral artery dissection is an uncommon, but potentially fatal, vascular event. This case aimed to describe the pathogenesis and clinical presentation of vertebral artery dissection in... | ASPIRIN, LEVOSULPIRIDE, PREDNISONE | DrugsGivenReaction | CC BY | 34670622 | 20,153,936 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Live birth'. | Vertebral artery dissection in term pregnancy after cervical spine manipulation: a case report and review the literature.
BACKGROUND
Vertebral artery dissection is an uncommon, but potentially fatal, vascular event. This case aimed to describe the pathogenesis and clinical presentation of vertebral artery dissection in... | ASPIRIN, LEVOSULPIRIDE, PREDNISONE | DrugsGivenReaction | CC BY | 34670622 | 20,153,936 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD.
Several risk factors for severe COVID-19 specific for patients with inflammatory rheumatic and musculoskeletal diseases (RMDs) have been identified so far. Evidence regardi... | APREMILAST | DrugsGivenReaction | CC BY-NC | 34670840 | 20,505,056 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal disorder'. | Pneumococcal Pneumonia Co-infection with Mycobacterium avium and Nocardia cyriacigeorgica in an Immunocompetent Patient.
A 61-year-old woman was transferred with a complaint of a fever and productive cough. She had tested positive for Mycobacterium avium and Nocardia cyriacigeorgica at least twice, and Streptococcus pn... | CEFTRIAXONE, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC-ND | 34670879 | 20,319,935 | 2021-10-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Pneumococcal Pneumonia Co-infection with Mycobacterium avium and Nocardia cyriacigeorgica in an Immunocompetent Patient.
A 61-year-old woman was transferred with a complaint of a fever and productive cough. She had tested positive for Mycobacterium avium and Nocardia cyriacigeorgica at least twice, and Streptococcus pn... | CEFTRIAXONE, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC-ND | 34670879 | 20,319,935 | 2021-10-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anger'. | Successful Treatment of Symptomatic Epilepsy with Oral Valproic Acid and Levetiracetam in a Patient with Short-bowel Syndrome: A Case Report.
Valproic acid (VPA) and levetiracetam (LEV) are used in epilepsy treatment. However, their use to treat short-bowel syndrome has not been reported. We herein report a 68-year-old... | DIAZEPAM, LEVETIRACETAM, VALPROIC ACID, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34670882 | 20,216,084 | 2021-10-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Successful Treatment of Symptomatic Epilepsy with Oral Valproic Acid and Levetiracetam in a Patient with Short-bowel Syndrome: A Case Report.
Valproic acid (VPA) and levetiracetam (LEV) are used in epilepsy treatment. However, their use to treat short-bowel syndrome has not been reported. We herein report a 68-year-old... | DIAZEPAM, LEVETIRACETAM, VALPROIC ACID, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34670882 | 20,216,084 | 2021-10-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dehydration'. | Successful Treatment of Symptomatic Epilepsy with Oral Valproic Acid and Levetiracetam in a Patient with Short-bowel Syndrome: A Case Report.
Valproic acid (VPA) and levetiracetam (LEV) are used in epilepsy treatment. However, their use to treat short-bowel syndrome has not been reported. We herein report a 68-year-old... | DIAZEPAM, LEVETIRACETAM, VALPROIC ACID, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34670882 | 20,216,084 | 2021-10-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug level increased'. | Successful Treatment of Symptomatic Epilepsy with Oral Valproic Acid and Levetiracetam in a Patient with Short-bowel Syndrome: A Case Report.
Valproic acid (VPA) and levetiracetam (LEV) are used in epilepsy treatment. However, their use to treat short-bowel syndrome has not been reported. We herein report a 68-year-old... | DIAZEPAM, LEVETIRACETAM, VALPROIC ACID, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34670882 | 20,216,084 | 2021-10-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypophagia'. | Successful Treatment of Symptomatic Epilepsy with Oral Valproic Acid and Levetiracetam in a Patient with Short-bowel Syndrome: A Case Report.
Valproic acid (VPA) and levetiracetam (LEV) are used in epilepsy treatment. However, their use to treat short-bowel syndrome has not been reported. We herein report a 68-year-old... | DIAZEPAM, LEVETIRACETAM, VALPROIC ACID, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34670882 | 20,216,084 | 2021-10-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mesenteric arterial occlusion'. | Successful Treatment of Symptomatic Epilepsy with Oral Valproic Acid and Levetiracetam in a Patient with Short-bowel Syndrome: A Case Report.
Valproic acid (VPA) and levetiracetam (LEV) are used in epilepsy treatment. However, their use to treat short-bowel syndrome has not been reported. We herein report a 68-year-old... | LEVETIRACETAM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34670882 | 20,220,507 | 2021-10-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Somnolence'. | Successful Treatment of Symptomatic Epilepsy with Oral Valproic Acid and Levetiracetam in a Patient with Short-bowel Syndrome: A Case Report.
Valproic acid (VPA) and levetiracetam (LEV) are used in epilepsy treatment. However, their use to treat short-bowel syndrome has not been reported. We herein report a 68-year-old... | DIAZEPAM, LEVETIRACETAM, VALPROIC ACID, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 34670882 | 20,216,084 | 2021-10-19 |
What was the administration route of drug 'VALPROIC ACID'? | Successful Treatment of Symptomatic Epilepsy with Oral Valproic Acid and Levetiracetam in a Patient with Short-bowel Syndrome: A Case Report.
Valproic acid (VPA) and levetiracetam (LEV) are used in epilepsy treatment. However, their use to treat short-bowel syndrome has not been reported. We herein report a 68-year-old... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34670882 | 20,220,507 | 2021-10-19 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.